ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study.

Lavinia Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.